Genmab A/S Cash Flow Conversion Efficiency

Latest as of September 2025: 0.093x

Genmab A/S cash flow conversion efficiency. Based on the latest financial reports, Genmab A/S (GMAB) has a cash flow conversion efficiency ratio of 0.093x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Dkr536.00 Million ≈ $83.86 Million USD) by net assets (Dkr5.75 Billion ≈ $899.79 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Genmab A/S (2002–2024)

Cash flow conversion efficiency of Genmab A/S from 2002 to 2024. This chart illustrates how Genmab A/S's cash flow conversion efficiency has evolved over time, based on yearly financial data. View GMAB stock price for real-time trading data and today's change.

Genmab A/S Cash Flow Conversion Ratio Explained

Genmab A/S cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Genmab A/S Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Genmab A/S ranked by their cash flow conversion efficiency. Also see GMAB market cap overview for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
CBRE Group Inc Class A NYSE:CBRE	-0.093x
CTBC Financial Holding Co Ltd Pref TW:2891B	-0.031x
DEUTSCHE BOERSE ADR 1/10 F:63DA	N/A
RWE AG XETRA:RWE	0.060x
Zscaler Inc NASDAQ:ZS	0.226x
UTD OV. BK-LOC-ADR/1 SD 1 F:UOB0	N/A
Bayerische Motoren Werke Aktiengesellschaft XETRA:BMW	0.017x
Chipotle Mexican Grill Inc NYSE:CMG	0.271x

Annual Cash Flow Conversion Efficiency for Genmab A/S (2002–2024)

The table below shows the annual cash flow conversion efficiency of Genmab A/S from 2002 to 2024. Review Genmab A/S free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	Dkr36.70 Billion ≈ $5.74 Billion	Dkr7.77 Billion ≈ $1.22 Billion	0.212x	-9.30%
2023-12-31	Dkr31.61 Billion ≈ $4.95 Billion	Dkr7.38 Billion ≈ $1.15 Billion	0.233x	+62.82%
2022-12-31	Dkr27.28 Billion ≈ $4.27 Billion	Dkr3.91 Billion ≈ $612.06 Million	0.143x	+42.85%
2021-12-31	Dkr22.20 Billion ≈ $3.47 Billion	Dkr2.23 Billion ≈ $348.59 Million	0.100x	-70.16%
2020-12-31	Dkr19.12 Billion ≈ $2.99 Billion	Dkr6.43 Billion ≈ $1.01 Billion	0.336x	+256.43%
2019-12-31	Dkr14.05 Billion ≈ $2.20 Billion	Dkr1.33 Billion ≈ $207.46 Million	0.094x	-25.45%
2018-12-31	Dkr8.01 Billion ≈ $1.25 Billion	Dkr1.01 Billion ≈ $158.77 Million	0.127x	-50.02%
2017-12-31	Dkr6.27 Billion ≈ $981.33 Million	Dkr1.59 Billion ≈ $248.61 Million	0.253x	+273.12%
2016-12-31	Dkr4.83 Billion ≈ $755.17 Million	Dkr327.72 Million ≈ $51.27 Million	0.068x	-23.99%
2015-12-31	Dkr3.49 Billion ≈ $545.52 Million	Dkr311.45 Million ≈ $48.73 Million	0.089x	+36.87%
2014-12-31	Dkr2.03 Billion ≈ $318.07 Million	Dkr132.67 Million ≈ $20.76 Million	0.065x	+133.63%
2013-12-31	Dkr659.52 Million ≈ $103.19 Million	Dkr-128.00 Million ≈ $-20.03 Million	-0.194x	-204.86%
2012-12-31	Dkr383.19 Million ≈ $59.95 Million	Dkr70.92 Million ≈ $11.10 Million	0.185x	+120.59%
2011-12-31	Dkr486.42 Million ≈ $76.10 Million	Dkr-437.23 Million ≈ $-68.41 Million	-0.899x	-462.02%
2010-12-31	Dkr1.08 Billion ≈ $168.98 Million	Dkr268.17 Million ≈ $41.96 Million	0.248x	+156.50%
2009-12-31	Dkr1.30 Billion ≈ $202.96 Million	Dkr-570.06 Million ≈ $-89.19 Million	-0.439x	-87.36%
2008-12-31	Dkr2.19 Billion ≈ $342.42 Million	Dkr-513.33 Million ≈ $-80.31 Million	-0.235x	-233.68%
2007-12-31	Dkr2.88 Billion ≈ $451.11 Million	Dkr505.90 Million ≈ $79.15 Million	0.175x	+174.30%
2006-12-31	Dkr1.61 Billion ≈ $251.52 Million	Dkr-379.62 Million ≈ $-59.39 Million	-0.236x	-26.62%
2005-12-31	Dkr1.12 Billion ≈ $175.04 Million	Dkr-208.64 Million ≈ $-32.64 Million	-0.186x	+40.10%
2004-12-31	Dkr1.18 Billion ≈ $184.77 Million	Dkr-367.70 Million ≈ $-57.53 Million	-0.311x	-11.87%
2003-12-31	Dkr1.09 Billion ≈ $169.98 Million	Dkr-302.36 Million ≈ $-47.31 Million	-0.278x	-26.30%
2002-12-31	Dkr1.40 Billion ≈ $218.91 Million	Dkr-308.32 Million ≈ $-48.24 Million	-0.220x	--

About Genmab A/S

CO:GMAB Denmark Biotechnology

Market Cap

$37.70 Billion

Dkr240.98 Billion DKK

Market Cap Rank

#710 Global

#4 in Denmark

Share Price

Dkr3912.00

Change (1 day)

+3.27%

52-Week Range

Dkr1524.00 - Dkr3912.00

All Time High

Dkr3912.00